Haverkamp W - Search Results

1

Genetic variations of KCNQ1, KCNH2, SCN5A, KCNE1, and KCNE2 in drug-induced long QT syndrome patients.

Paulussen AD, Gilissen RA, Armstrong M, Doevendans PA, Verhasselt P, Smeets HJ, Schulze-Bahr E, Haverkamp W, Breithardt G, Cohen N, Aerssens J. Paulussen AD, et al. Among authors: haverkamp w. J Mol Med (Berl). 2004 Mar;82(3):182-8. doi: 10.1007/s00109-003-0522-z. Epub 2004 Feb 4. J Mol Med (Berl). 2004. PMID: 14760488

2

Identification and functional characterization of a novel KCNE2 (MiRP1) mutation that alters HERG channel kinetics.

Isbrandt D, Friederich P, Solth A, Haverkamp W, Ebneth A, Borggrefe M, Funke H, Sauter K, Breithardt G, Pongs O, Schulze-Bahr E. Isbrandt D, et al. Among authors: haverkamp w. J Mol Med (Berl). 2002 Aug;80(8):524-32. doi: 10.1007/s00109-002-0364-0. Epub 2002 Jun 28. J Mol Med (Berl). 2002. PMID: 12185453

3

Molecular analysis at the Harvey Ras-1 gene in patients with long QT syndrome.

Schulze-Bahr E, Haverkamp W, Wiebusch H, Schulte H, Hördt M, Borggrefe M, Breithardt G, Assmann G, Funke H. Schulze-Bahr E, et al. Among authors: haverkamp w. J Mol Med (Berl). 1995 Nov;73(11):565-9. doi: 10.1007/BF00195141. J Mol Med (Berl). 1995. PMID: 8751140

4

A novel long-QT 5 gene mutation in the C-terminus (V109I) is associated with a mild phenotype.

Schulze-Bahr E, Schwarz M, Hauenschild S, Wedekind H, Funke H, Haverkamp W, Breithardt G, Pongs O, Isbrandt D. Schulze-Bahr E, et al. Among authors: haverkamp w. J Mol Med (Berl). 2001 Sep;79(9):504-9. doi: 10.1007/s001090100249. J Mol Med (Berl). 2001. PMID: 11692163

5

Sodium channel gene (SCN5A) mutations in 44 index patients with Brugada syndrome: different incidences in familial and sporadic disease.

Schulze-Bahr E, Eckardt L, Breithardt G, Seidl K, Wichter T, Wolpert C, Borggrefe M, Haverkamp W. Schulze-Bahr E, et al. Among authors: haverkamp w. Hum Mutat. 2003 Jun;21(6):651-2. doi: 10.1002/humu.9144. Hum Mutat. 2003. PMID: 14961552

6

Sudden infant death syndrome and long QT syndrome: an epidemiological and genetic study.

Wedekind H, Bajanowski T, Friederich P, Breithardt G, Wülfing T, Siebrands C, Engeland B, Mönnig G, Haverkamp W, Brinkmann B, Schulze-Bahr E. Wedekind H, et al. Among authors: haverkamp w. Int J Legal Med. 2006 May;120(3):129-37. doi: 10.1007/s00414-005-0019-0. Epub 2005 Jul 13. Int J Legal Med. 2006. PMID: 16012827

7

Drug-induced sudden cardiac death.

Haverkamp W, Breithardt G. Haverkamp W, et al. Eur Heart J. 2005 Sep;26(17):1808-9; author reply 1809. doi: 10.1093/eurheartj/ehi401. Epub 2005 Jul 13. Eur Heart J. 2005. PMID: 16014647 No abstract available.

8

The long-QT syndrome.

Schulze-Bahr E, Haverkamp W, Funke H. Schulze-Bahr E, et al. Among authors: haverkamp w. N Engl J Med. 1995 Dec 28;333(26):1783-4. N Engl J Med. 1995. PMID: 7491156 No abstract available.

9

Autosomal recessive long-QT syndrome (Jervell Lange-Nielsen syndrome) is genetically heterogeneous.

Schulze-Bahr E, Haverkamp W, Wedekind H, Rubie C, Hördt M, Borggrefe M, Assmann G, Breithardt G, Funke H. Schulze-Bahr E, et al. Among authors: haverkamp w. Hum Genet. 1997 Oct;100(5-6):573-6. doi: 10.1007/s004390050554. Hum Genet. 1997. PMID: 9341873

10

Physician-induced torsade de pointes--therapeutic implications.

Haverkamp W, Mönnig G, Schulze-Bahr E, Haverkamp F, Breithardt G. Haverkamp W, et al. Among authors: haverkamp f. Cardiovasc Drugs Ther. 2002 Mar;16(2):101-9. doi: 10.1023/a:1015797214679. Cardiovasc Drugs Ther. 2002. PMID: 12090902 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

417 results

Search Page

Filters